MoonLake Immunotherapeutics (MLTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday.

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced the completion of the dosing and initial follow-up period for ...

Global Healthy Living Foundation has 12 posters and Polymyalygia Rheumataca, Psoriasis and RA Research at American College of ...

The following is a summary of “Association between depression and anxiety and inability to achieve remission in rheumatoid ...

“Seeking treatment is a very ... “There are many options to treat psoriatic arthritis, like COSENTYX, which may help provide relief and reduce symptoms. As a healthcare professional, I ...

Similar percentages of patients with PsA receiving secukinumab vs adalimumab achieved an ACR20 response at 12 weeks.

Kenderick Lee was 24 and carving out a successful career in the corporate world when a diagnosis of the skin disease ...

Researchers at the University of Massachusetts Amherst have invented a new, sprayable delivery system for psoriasis ...

A young woman who isn’t expected to live past 50 is hitting out at NDIS funding claiming decisions being made are a “mind ...

Kristen Whitney, DO, FAAD, dermatologist at Allegheny Health Network, explored the intricate management of alopecia areata, ...

The Food and Drug Administration (FDA) has approved a new presentation of Selarsdi ™ (ustekinumab-aekn), a biosimilar to Stelara ® (ustekinumab), expanding the product’s indications to include ...

For example, one person with psoriatic arthritis may respond well to a TNF ... Biologics can be used as first-line treatment for some conditions. However, your doctor may recommend starting ...